Hatteras Venture Advisors III, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hatteras Venture Advisors III, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hatteras Venture Advisors III, LLC. Hatteras Venture Advisors III, LLC is 10% Owner in PhaseBio Pharmaceuticals Inc ($PHAS) and 10% Owner in Clearside Biomedical, Inc. ($CLSD).
Latest Insider Trading Transactions of Hatteras Venture Advisors III, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 226,061 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 24,709 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 272,107 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 40,420 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 13,558 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 149,320 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 94,874 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 1,044,764 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 13,609 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 174,699 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 4,846 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 3,862 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 42,530 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 52,690 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | S | 0.00 | 994 | 0 | 40,420 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.00 | 41,414 | 0 | 41,414 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.12 | 41,414 | 4,970 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | S | 0.00 | 104 | 0 | 13,558 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.00 | 4,309 | 0 | 13,662 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.12 | 4,309 | 517 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | S | 0.00 | 1,139 | 0 | 149,320 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.00 | 47,458 | 0 | 150,459 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.12 | 47,458 | 5,695 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | S | 0.00 | 42 | 0 | 94,874 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.00 | 1,731 | 0 | 94,916 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.12 | 1,731 | 208 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | S | 0.00 | 458 | 0 | 1,044,764 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.00 | 19,061 | 0 | 1,045,222 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.12 | 19,061 | 2,287 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | P | 5.00 | 150,000 | 750,000 | 416,481 | 266.5 K to 416.5 K (+56.29 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | C | 0.00 | 266,481 | 0 | 266,481 | 0 to 266.5 K |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | C | 0.00 | 4,846 | 0 | 4,846 | 0 to 4.8 K |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | P | 5.00 | 12,487 | 62,435 | 163,099 | 150.6 K to 163.1 K (+8.29 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | C | 0.00 | 150,612 | 0 | 150,612 | 0 to 150.6 K |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | P | 5.00 | 137,513 | 687,565 | 1,820,933 | 1.7 M to 1.8 M (+8.17 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | C | 0.00 | 1,683,420 | 0 | 1,683,420 | 0 to 1.7 M |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | C | 0.00 | 52,690 | 0 | 52,690 | 0 to 52.7 K |
Jan 19 2017 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Sell | S | 8.22 | 6,478 | 53,249 | 1,757,719 | 1.8 M to 1.8 M (-0.37 %) |
Jan 19 2017 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Sell | S | 8.64 | 10,457 | 90,348 | 1,764,197 | 1.8 M to 1.8 M (-0.59 %) |
Jan 19 2017 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Sell | S | 8.92 | 8,366 | 74,625 | 1,774,654 | 1.8 M to 1.8 M (-0.47 %) |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.02 | 1,805 | 40 | 0 | |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | X | 0.02 | 19,900 | 438 | 0 | |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 337,898 | 0 | 0 | |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 432,940 | 0 | 0 | |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 689,388 | 0 | 0 | |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Option Exercise | C | 0.00 | 2,035,907 | 0 | 0 | |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | P | 7.00 | 107,142 | 749,994 | 1,783,020 | 1.7 M to 1.8 M (+6.39 %) |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Sell | S | 7.00 | 69 | 483 | 1,675,878 | 1.7 M to 1.7 M (0.00 %) |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | X | 0.02 | 21,705 | 478 | 1,675,947 | 1.7 M to 1.7 M (+1.31 %) |
Jun 07 2016 | CLSD | Clearside Biomedic ... | Hatteras Venture Advisors III, ... | 10% Owner | Buy | C | 0.00 | 1,598,219 | 0 | 1,654,242 | 56 K to 1.7 M (+2,852.79 %) |
Page: 1